Childhood Langerhans cell histiocytosis with severe lung involvement: A nationwide cohort study - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Orphanet Journal of Rare Diseases Année : 2020

Childhood Langerhans cell histiocytosis with severe lung involvement: A nationwide cohort study

Solenne Le Louet
  • Fonction : Auteur correspondant
  • PersonId : 1083629

Connectez-vous pour contacter l'auteur
Jean Miron
  • Fonction : Auteur
Nathalie Aladjidi
  • Fonction : Auteur
Ralph Epaud

Résumé

Background: Lung involvement in childhood Langerhans cell histiocytosis (LCH) is infrequent and rarely life threatening, but occasionally, severe presentations are observed. Methods: Among 1482 children (< 15 years) registered in the French LCH registry (1994-2018), 111 (7.4%) had lung involvement. This retrospective study included data for 17 (1.1%) patients that required one or more intensive care unit (ICU) admissions for respiratory failure. Results: The median age was 1.3 years at the first ICU hospitalization. Of the 17 patients, 14 presented with lung involvement at the LCH diagnosis, and 7 patients (41%) had concomitant involvement of risk-organ (hematologic, spleen, or liver). Thirty-five ICU hospitalizations were analysed. Among these, 22 (63%) were secondary to a pneumothorax, 5 (14%) were associated with important cystic lesions without pneumothorax, and 8 (23%) included a diffuse micronodular lung infiltration in the context of multisystem disease. First-line vinblastine-corticosteroid combination therapy was administered to 16 patients; 12 patients required a second-line therapy (cladribine: n = 7; etoposide-aracytine: n = 3; targeted therapy n = 2). A total of 6 children (35%) died (repeated pneumothorax: n = 3; diffuse micronodular lung infiltration in the context of multisystem disease: n = 2; following lung transplantation: n = 1). For survivors, the median follow-up after ICU was 11.2 years. Among these, 9 patients remain asymptomatic despite abnormal chest imaging. Conclusions: Severe lung involvement is unusual in childhood LCH, but it is associated with high mortality. Treatment guidelines should be improved for this group of patients: viral infection prophylaxis and early administration of a new LCH therapy, such as targeted therapy.

Domaines

Génétique
Fichier principal
Vignette du fichier
s13023-020-01495-5.pdf (6.35 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-03032330 , version 1 (07-06-2023)

Licence

Identifiants

Citer

Solenne Le Louet, Mohamed Aziz Barkaoui, Jean Miron, Claire Galambrun, Nathalie Aladjidi, et al.. Childhood Langerhans cell histiocytosis with severe lung involvement: A nationwide cohort study. Orphanet Journal of Rare Diseases, 2020, 15 (1), ⟨10.1186/s13023-020-01495-5⟩. ⟨hal-03032330⟩
73 Consultations
11 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More